key: cord-0780151-v1kozp4s
authors: Sikkema, R. S.; Pas, S.; Nieuwenhuijse, D. F.; O'Toole, A.; Verweij, J.; van der Linden, A.; Chestakova, I.; Schapendonk, C.; Pronk, M. R.; Lexmond, P.; Bestebroer, T.; Overmars, R. J.; van Nieuwkoop, S.; van den Bijllaardt, W.; Bentvelsen, R. G.; van Rijen, M. M. L.; Buiting, A. G. M.; van Oudheusden, A. J. G.; Diederen, B. M.; Bergmans, A. M. C.; van der Eijk, A.; Molenkamp, R.; Rambaut, A.; Timen, A.; Kluytmans, J. A. J. W.; Oude Munnink, B. B.; Kluytmans, M.; Koopmans, M. P. G.
title: COVID-19 in healthcare workers in three hospitals in the South of the Netherlands, March 2020
date: 2020-05-01
journal: nan
DOI: 10.1101/2020.04.26.20079418
sha: 8665c472447de7ef27c2d3e3ecc36d22304fcf93
doc_id: 780151
cord_uid: v1kozp4s

Background: Ten days after the first reported case of SARS-CoV-2 infection in the Netherlands, 3.9% of healthcare workers (HCWs) in nine hospitals located in the South of the Netherlands tested positive for SARS-CoV-2 RNA. The extent of nosocomial transmission that contributed to the HCW infections was unknown. Methods: We combined epidemiological data, collected by means of structured interviews of HCWs, with whole genome sequencing (WGS) of SARS-CoV-2 in clinical samples from HCWs and patients in three of nine hospitals that participated in the HCW screening, to perform an in-depth analysis of sources and modes of transmission of SARS -CoV-2 in HCWs and patients. Results: A total of 1,796 out of 12,022 HCWs (15%) of the three participating hospitals were screened, based on clinical symptoms, of whom 96 (5%) tested positive for SARS-CoV-2. We obtained complete genome sequences of 50 HCWs and 18 patients. Most sequences grouped in 3 clusters, with 2 clusters displaying local circulation within the region. The observed patterns are most consistent with multiple introductions into the hospitals through community acquired infections, and local amplification in the community. Conclusions: Although direct transmission in the hospitals cannot be ruled out, the data does not support widespread nosocomial transmission as source of infection in patients or healthcare workers.

Although direct transmission in the hospitals cannot be ruled out, the data does not support widespread nosocomial transmission as source of infection in patients or healthcare workers.

Early December 2019 an outbreak caused by a novel coronavirus, linked to a seafood and live animal wholesale market in Wuhan, China was discovered 1 . The clinical spectrum of disease varies from asymptomatic or mild symptomatic infections to severe respiratory symptoms and mortality, with older age groups generally presenting with more severe disease and higher death rates 2,3 . Since its discovery, SARS-CoV-2 has rapidly spread across the globe. On April 22nd a total of 177 countries reported SARS-CoV-2, adding up to over 2,590,000 reported cases and more than 179,000 deaths worldwide 4 .

Healthcare workers (HCWs) are at greater risk of being exposed to SARS-CoV-2 and could potentially play a role in hospital outbreaks. Nosocomial outbreaks of SARS-CoV and MERS-CoV are thought to have played a crucial role in the amplification and spread of these viruses. For MERS-CoV, hospital outbreaks have been responsible for approximately 50% of confirmed human cases, of which around 40% were healthcare workers 5, 6 . Currently the extent of SARS-CoV-2 transmission in health care settings is unclear, as well as risk factors associated with infection in health care settings. During the WHO-China Joint Mission on coronavirus disease 2019 (COVID-19) 2,055 laboratory-confirmed healthcare workers from 476 hospitals were reported, mostly from Hubei province (88%). Most HCW infections were thought to have been infected within household settings rather than in a health care setting, although conclusive evidence was lacking 3 .

On February 27, the first Dutch patient tested positive for SARS-CoV-2 RNA after a holiday to Lombardy, Italy 7 . In the following week, the number of cases increased to 128, with an increasing proportion of cases without a known source of infection. These cases included nine HCWs from two hospitals in North Brabant, in the South of the Netherlands 2,8 .

Therefore, the Dutch national Outbreak Management Team advised to extend this screening of HCWs to other hospitals in the province of North Brabant, to assess possible community transmission. From March 6 th to March 8 th , 1,097 employees of nine hospitals were tested of which 3.9% was found to be positive for SARS-CoV-2 8 . A follow up study was done at three hospitals to assess the clinical presentations of COVID-19 of these HCWs 2 , and in the present study an in-depth investigation was done to understand sources and modes of transmission. The scarcity of personal protective equipment led to changes in policy during the initial phases of the outbreak response, also triggering a debate on possible risks to HCW.

Here, we combined epidemiological data with whole genome sequencing of SARS-CoV-2 in clinical samples from HCWs and patients in three different hospitals to perform an in-depth analysis of sources and modes of transmission of SARS -CoV-2 in HCWs and patients in the same hospitals.

A cross-sectional study was conducted in two teaching hospitals (700-bed Amphia Hospital, Breda, the Netherlands; 800-bed Elisabeth-TweeSteden Hospital, Tilburg, the . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 1, 2020. . https://doi.org/10.1101/2020.04. 26.20079418 doi: medRxiv preprint Netherlands, the Netherlands) and one regional hospital (600-bed Bravis Hospital, Roosendaal and Bergen op Zoom), employing a total of 12,022 HCWs. Between March 2, 2020 and March 12, 2020, HCWs in these three hospitals who experienced fever or mild respiratory symptoms in the last ten days were voluntarily tested for SARS-CoV-2 infection using oro-/nasalpharyngeal swabs in universal transport medium or E-swab medium (Copan, Italy), following the local infection control policy during outbreaks.

Structured interviews were conducted to document history of foreign travel and attendance of public events with more than 50 persons, such as the yearly carnival in February, for all HCWs with confirmed SARS-CoV-2 infection (Annex 2 -questionnaire).

Ethical approval was obtained from the Ethics Committee Brabant, with a waiver of written informed consent (METC Brabant/20.134/NW2020-26). Verbal informed consent was obtained from all HCWs for SARS-CoV-2 testing, sequencing and data collection. Data was de-identified before analysis.

In the Bravis and Amphia hospital, total nucleic acids were extracted after an external lysis step (1:1 with lysis/binding buffer (Roche Diagnostics, the Netherlands), using MagnaPure96 (Roche) with an input volume of 500 µl and output volume of 100 µl. The 

Samples were selected based on cycle threshold (Ct) value (<32). A SARS-CoV-2 specific multiplex PCR for Nanopore sequencing was performed, similar to amplicon-based approaches as previously described 12, 13 . The resulting raw sequence data was demultiplexed using qcat (https://github.com/nanoporetech/qcat). Primers were trimmed using cutadapt 14 after which a reference based alignment was performed using minimap2 15 to GISAID sequence EPI_ISL_412973. The consensus genome was extracted and positions with a coverage <30 were replaced with an "N" with a custom script using biopython and pysam, as previously described 12 . Mutations in the genome were confirmed by manually checking the alignment and homopolymeric regions were manually checked and resolved consulting the reference genome. Complete whole genomes were defined as having >90% genome coverage.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2020. . All available full-length SARS-CoV-2 genomes were retrieved from GISAID 16 on March 20 2020 and aligned with the newly obtained SARS-CoV-2 sequences in this study using MUSCLE 17 . Sequences with >10% "Ns" were excluded. The alignment was manually checked for discrepancies after which IQ-TREE 18 was used to perform a maximum likelihood phylogenetic analysis with the GTR+F+I +G4 model as best predicted model.

The ultrafast bootstrap option was used with 1,000 replicates.

Clusters 1 (B2), 2 (B) and 3 (B1) were determined based on visual clustering as well as lineage designations as proposed by Rambaut et al 19 .

The same alignment as for the maximum likelihood phylogenetic analysis was used to create a minimum spanning tree (MST). The code to generate the MST was written in the R programming language. The ape 20 

The multiple sequence alignment was curated and any error-rich sequences or sequences without a date were removed. The alignment was manually inspected and trimmed of the 5' and 3' UTRs in Geneious v11.1.3 (geneious.com) to include only coding regions. The final length of the alignment was 29,408 nucleotides. Bayesian phylogenetic trees were . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2020. . https://doi.org/10.1101/2020.04. 26.20079418 doi: medRxiv preprint estimated using BEAST v1.10.4 22 using an HKY nucleotide subsititution model 23 and a strict molecular clock. Two independent chains were run for 100 million states, with a skygrid coalescent prior 24, 25 . Trees and parameters were sampled every 10,000 states.

LogCombiner was used to combine the independent chains and to remove the burn-in from the tree file and Tracer was used to assess convergence 26 . The maximum clade credibility (MCC) tree was inferred using TreeAnnotator and visualized using baltic (https://github.com/evogytis/baltic) and custom python scripts.

Epidemiological data, as collected by the structured interviews, were entered in CASTOR (Table 1) . Twenty staff members without direct patient contact tested positive for SARS-CoV-2 RNA, six of whom (30%) reported contact with . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2020. Most HCW sequences in this study (46/50; 92%) grouped in three clusters ( Figure 1A ; Annex 1). Cluster 1 contains 21 out of 68 sequences in this study, ten of which are identical. 90% (19/21) of these sequences originated from HCWs and patients of the Amphia hospital, compared to 41% of the sequences in cluster 2 (14/34). HCWs in cluster 1 were associated with Prinsenbeek and Breda, either by carnival or residence, more often compared to the other clusters ( Figure 1A ; Figure 1B ; Table 2 ). Cluster 2 contained 34 sequences including 19 identical sequences, of HCWs from all three hospitals, including 85% of ETZ hospital

HCWs, unlike what was observed for cluster 1 ( Figure 1A ; Figure 1B ; Table 2 ). The third cluster contained a small part of HCWs from this study, but reflects a larger cluster of . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2020. . https://doi.org/10.1101/2020.04. 26.20079418 doi: medRxiv preprint sequences from persons with travel history to Italy, as described elsewhere 13 . However, only two of six HCWs in this cluster reported to have traveled to either Italy or Austria.

Within each cluster identical or near identical sequences in HCWs in the same hospital as well as patients and HCWs were found, but there was no consistent link among HCWs on the same ward, and between HCWs and patients at the same ward. There were no clusters of more than two HCWs on the same ward with identical or near identical (1 nucleotide difference) sequences. Therefore, the observed patterns are most consistent with multiple introductions through community acquired infections, and some local amplification related to specific social events in the community. Although direct transmission in the hospitals cannot be ruled out, the data does not support widespread nosocomial transmission as source of infection in patients or healthcare workers.

In the present study we combined epidemiological data with whole genome sequencing to Healthcare workers are at increased risk of being exposed to viruses within hospitals, but can also be a source of transmission by introducing a virus into their hospital. SARS-CoV-2 infections in HCWs can have a significant impact, since pathogens are introduced into settings with high numbers of individuals with co-morbidities, potentially causing high morbidity and mortality amongst patients. The current study did not find evidence of large scale nosocomial transmission, and prevailing use of PPE and other infectious disease prevention measures were considered sufficient based on these early analyses and results.

Outbreaks in healthcare settings are traditionally investigated by molecular diagnostic tools combined with epidemiological data. However, previous studies using WGS for hospital outbreak investigations have shown that the hypotheses on virus transmission routes can be incorrect based solely on these data. By adding WGS data, especially if results can be generated in a timely manner, and provided that sufficient reference sequences are available to allow a high resolution of the findings, the sequence analysis can provide essential information and inform subsequent infection control measures 29, 30 .

The mutation rate of SARS-CoV-2 is estimated to be around 1.16*10^-3 substitutions/site/year, which corresponds to around one mutation per two weeks 31 . Therefore, finding identical or near identical sequences in several locations and hospitals, makes it difficult to draw definite conclusions on individual direct HCW-to-HCW or HCW-topatient transmissions based on sequence data alone in this early stage of the SARS-CoV-2 outbreak, when the level of genetic diversity of the circulating pathogen still is limited.

Moreover, we did not obtain WGS of all positive HCWs. However, the finding of diverse . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2020. . https://doi.org/10.1101/2020.04. 26.20079418 doi: medRxiv preprint clusters does exclude infection from a single source. In addition, the sequence-based analysis may be biased when sampling and sequencing is not done systematically and sequence data in some areas is scarce as is the case for COVID-19 internationally. For the Netherlands, we sequenced a significant proportion of SARS-CoV-2 genomes as part of the national public health response 13 , which was used as a reference set.

We conclude that the observed genomic diversity likely reflects HCW infections contracted outside of the hospital rather than widespread within hospital transmission. Due to the near- . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2020. 20 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 1, 2020. Figure 1A . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 1, 2020. . https://doi.org/10.1101/2020.04. 26.20079418 doi: medRxiv preprint Figure 1B . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 1, 2020. . https://doi.org/10.1101/2020.04. 26.20079418 doi: medRxiv preprint Figure 1C . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 1, 2020. . https://doi.org/10.1101/2020.04. 26.20079418 doi: medRxiv preprint 

A Novel Coronavirus from Patients with Pneumonia in China

SARS-CoV-2 infection in 86 healthcare workers in two Dutch hospitals in

An interactive web-based dashboard to track COVID-19 in real time

Comparative Analysis of Eleven Healthcare-Associated Outbreaks of Middle East Respiratory Syndrome Coronavirus (Mers-Cov) from 2015 to 2017

COVID-19: patiënt nul in Nederland

Rapid assessment of regional SARS-CoV-2 community transmission through a convenience sample of healthcare workers, the Netherlands

Incidence of viral respiratory pathogens causing exacerbations in adult cystic fibrosis patients

Molecular assays for quantitative and qualitative detection of influenza virus and oseltamivir resistance mutations

Validating Whole Genome Nanopore Sequencing, using Usutu Virus as an Example

Rapid SARS-CoV-2 whole genome sequencing for informed public health decision making in the Netherlands

Cutadapt removes adapter sequences from high-throughput sequencing reads

Minimap2: pairwise alignment for nucleotide sequences

Global initiative on sharing all influenza data -from vision to reality

MUSCLE: multiple sequence alignment with high accuracy and high throughput

IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era

A dynamic nomenclature proposal for SARS-CoV-2 to assist genomic epidemiology

ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R

The igraph software package for complex network research

Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10

Dating of the human-ape splitting by a molecular clock of mitochondrial DNA

Improving Bayesian population dynamics inference: a coalescent-based model for multiple loci

Bayesian estimation of past population dynamics in BEAST 1.10 using the Skygrid coalescent model

Posterior Summarization in

Epidemiology of Covid-19 in a Long-Term Care Facility in King County

Death from Covid-19 of 23 Health Care Workers in China

Real-time Metagenomic Sequencing During Norovirus Outbreak Reveals Discrete Transmission Clusters

The Lancet Respiratory M. COVID-19: delay, mitigate, and communicate

We acknowledge David van der Vijver (ErasmusMC) and Harry Vennema (RIVM) for technical support.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2020. . https://doi.org/10.1101/2020.04. 26.20079418 doi: medRxiv preprint